Company Overview of FORUM Pharmaceuticals Inc.
FORUM Pharmaceuticals Inc. develops life-changing medicines for the treatment of serious brain diseases. Its products include Gamma secretase modulation, an approach to reduce Abeta42 production; HDAC program, an activity of HDAC has an impact on brain diseases that display abnormalities in the gene transcription; PDE 10 program, an investigational phosphodiesterase inhibitor; and alpha-7 Receptor agonists, an orally administered encenicline hydrochloride. The company provides its therapies for Alzheimer's disease and Schizophrenia. FORUM Pharmaceuticals Inc. was formerly known as EnVivo Pharmaceuticals, Inc. and changed its name to FORUM Pharmaceuticals Inc. in April 2014. The company was f...
500 Arsenal Street
Watertown, MA 02472
Founded in 2001
Key Executives for FORUM Pharmaceuticals Inc.
Chief Financial Officer and Senior Vice President
Chief Scientific Officer and Senior Vice President of Research
Vice President and General Counsel
Chief Medical Officer and Senior Vice President of Clinical Development
Compensation as of Fiscal Year 2014.
FORUM Pharmaceuticals Inc. Key Developments
FORUM Pharmaceuticals Inc. Appoints Christine Boisclair as Vice President, Regulatory Affairs
Jul 9 14
FORUM Pharmaceuticals Inc. announced the appointment of Christine Boisclair as Vice President, Regulatory Affairs. In this role, she will provide oversight for all aspects of the company's U.S. and international regulatory matters. Ms. Boisclair brings more than 20 years of regulatory affairs experience in the biotechnology and pharmaceutical industries to FORUM and will report to Dana C. Hilt, M.D., Senior Vice President Clinical Development and Chief Medical Officer. Prior to FORUM, Ms. Boisclair most recently served as Vice President, Regulatory Affairs at Insmed Incorporated and as Senior Vice President, Global Regulatory Affairs at Agennix Inc.
FORUM Pharmaceuticals Inc. Presents at Boston CEO Conference, Jun-04-2014
Jun 2 14
FORUM Pharmaceuticals Inc. Presents at Boston CEO Conference, Jun-04-2014. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, Massachusetts, United States. Presentation Date & Speakers: Jun-04-2014, Deborah Dunsire, Chief Executive Officer, President and Director. Jun-05-2014, Deborah Dunsire, Chief Executive Officer, President and Director.
FORUM Pharmaceuticals Inc. Appoints Todd Shegog as Senior Vice President and Chief Financial Officer
Apr 22 14
FORUM Pharmaceuticals Inc. announced the appointment of Todd Shegog as Senior Vice President and Chief Financial Officer. Prior to FORUM, Mr. Shegog served as Senior Vice President, Finance and Chief Financial Officer at Millennium Pharmaceuticals Inc., now Millennium: The Takeda Oncology Company, where he was responsible for management of the company's financial resources, corporate planning, financial reporting and compliance.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|